The latest on Medtronic’s drive to close the loop!
Type 1 Diabetes News
Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels.
71 readers recommended
58 readers recommended
"We want people to be able to take all the energy that goes into managing T1D and direct that effort to lives well lived."
Medtronic’s MiniMed 670G Hybrid-Closed Loop – Exclusive Interview with 17-Year-Old Trial Participant
48 readers recommended
Josh Airth, a 17-year old with type 1 diabetes, recently participated in a clinical trial of the Medtronic 670G "hybrid-closed loop"system (insulin pump + Enlite 3 CGM...
30 readers recommended
Twitter summary: CDC report shows most #PWD don’t receive adequate education at diagnosis, plus resources to help The CDC recently published a report on the...
57 readers recommended
The clinical trial is testing Medtronic’s 670G “hybrid-closed loop” system (insulin pump + Enlite 3 CGM sensor) in people with type 1 diabetes. Based on the Enlite 3 CGM...
39 readers recommended
"If you gave me a fully self-driving car today, I wouldn’t use it. It would take me many months before I could build the confidence. We can’t just give patients the...
32 readers recommended
We interview the five young scientists to watch.
43 readers recommended
Kelly and Adam weigh in on the Sanofi Partners in Patient Health Summit.
38 readers recommended
Find out if you qualify for this cutting-edge trial.
38 readers recommended
Twitter Summary: @AmDiabetesAssn selects Kevin Hagan as new CEO, stay tuned for our interview on his vision for #diabetes + the strengths he brings to ADA
55 readers recommended
Sleek design and a future meter + test strip subscription service – how this diabetes management solution hopes to stand out from the rest.
25 readers recommended
At the Navigate: The Atlantic Tech Conference , Jonathan Rosenberg (advisor to Google CEO Larry Page) stated that Google[x]’s smart contact lens is the “closest” to...
33 readers recommended
One of the highlights of this year’s ADA Exhibit Hall was NeuroMetrix’s Quell chronic pain management device. Quell is the over the counter version (no prescription...
38 readers recommended
A clinical trial takes a new approach to type 1 prevention research.
54 readers recommended
Twitter summary: #DBminesummit brings together top minds to discuss innovations in #diabetes – top 6 highlights below, full report coming soon! This past week, our team...
64 readers recommended
Snap pumpers can transition to other pump companies at low cost – find out details here.
36 readers recommended
Clinical Trial Identifier: NCT02283411 This 14-day study is testing the safety and accuracy of the “Abbott sensor based glucose monitoring system,” which we already know...
66 readers recommended
Sanofi and MannKind announce Afrezza's official US launch.